American Heart Association

Obese patients may be at higher risk of bleeding when taking warfarin

By AMERICAN HEART ASSOCIATION NEWS

Obese patients taking the frequently used blood thinner warfarin have a higher risk of bleeding than normal-weight patients taking the drug, according to a new study presented Friday at the American Heart Association’s Arteriosclerosis, Thrombosis and Vascular Biology/Peripheral Vascular Disease Scientific Sessions 2015.

Researchers conducted a one-year study […]

Long-term overtreatment with anti-clotting/antiplatelet drug combo raises risk of dementia in people with irregular heartbeat

Long-term overtreatment with the anti-clotting drug warfarin, combined with antiplatelet therapy with aspirin or clopidigrel to prevent stroke, raises the risk of dementia in people with atrial fibrillation, according to research presented at the American Heart Association’s Scientific Sessions 2014.

Atrial fibrillation is a common heart rhythm abnormality that raises […]

Patients should talk to doctors before changing dosage on anti-clotting drug

A recent report questions whether more could be done to prevent side-effects and improve effectiveness of the anti-clotting drug dabigatran, but medical experts urge people to continue taking the medication as prescribed unless their physician says otherwise.

The drug, sold under the brand name Pradaxa, is one of a relatively […]

Questions raised about managing dabigatran’s risks

Q. What did the British Medical Journal article say about dabigatran/Pradaxa and its manufacturer?

The journal released a report questioning whether drugmaker Boehringer-Ingelheim fully disclosed all it knew about how doctors could possibly lower the risk of bleeding side effects of Pradaxa by measuring blood levels or the anti-clotting effects […]